Endothelial NMMHC IIA Dissociation From PAR1 Activates the CREB3/ARF4 Signaling in Thrombin-Mediated Intracerebral Hemorrhage

    November 2024 in “ Journal of Advanced Research
    Yujie Dai, Lei Bao, Juan Huang, Miling Zhang, Xiaohong Yu, Yuanyuan Zhang, Fang Li, Boyang Yu, Shuaishuai Gong, Junping Kou
    TLDR Targeting NMMHC IIA may help treat blood-brain barrier damage.
    The study found that the dissociation of NMMHC IIA from PAR1 activates the CREB3/ARF4 signaling pathway, which exacerbates blood-brain barrier (BBB) damage caused by thrombin. This discovery suggests that NMMHC IIA could be a new therapeutic target for treating diseases related to BBB damage.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results